LSL Pharma Group Inc. (LSL.V)
| Previous Close | 0.4050 |
| Open | 0.4100 |
| Bid | 0.3900 x N/A |
| Ask | 0.4200 x N/A |
| Day's Range | 0.4000 - 0.4100 |
| 52 Week Range | 0.3500 - 0.5900 |
| Volume | |
| Avg. Volume | 38,991 |
| Market Cap | 39.408M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0500 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
GlobeNewswireLSL Pharma Group Secures $3.8 Million as the Second and Final Tranche of Its Private Placement of Units
BOUCHERVILLE, Quebec, April 24, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV: LSL) (the "Corporation" or "LSL Pharma"), a Canadian integrated pharmaceutical company, today announced the second and final tranche of its private placement financing of Units (as defined hereafter) for $3.8 million representing the second closing of the upsized $7.5 million non-brokered private placement announced on April 11, 2024 (the “Financing”). The second tranche follows an initial first closing of $2.7
- GlobeNewswire
LSL Pharma Group Announces the Addition of New Members to Its Board of Directors
BOUCHERVILLE, Quebec, April 23, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV: LSL) (the "Company" or "LSL Pharma"), a Canadian integrated pharmaceutical company, today announced the appointment of Diane Beaudry and Mario Paradis to its Board of Directors. "It is my pleasure and privilege to announce the addition of two new members to the LSL Pharma Group Board of Directors, including our first female representative," said Mr. François Roberge, Chairman of the Board. "Diane Beaudry and Ma
- GlobeNewswire
LSL Pharma Group Announces the Upsizing of Its Private Placement From $3.5 Million to $7.5 Million
BOUCHERVILLE, Québec, April 11, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV: LSL) (the "Corporation" or "LSL Pharma "), a Canadian integrated pharmaceutical company, today announced the upsizing of its previously communicated non-brokered private placement financing of Units (as defined hereinafter) to maximum gross proceeds of $7.5 million (188 750 000 Units) (the “Financing”). The upsizing follows an initial first closing of $2.68 million announced on March 18, 2024 concurrent to conv
